IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Servier
Centre Leon Berard
Ricoh USA, Inc.
Quironsalud
Istituto Ortopedico Rizzoli
Var2 Pharmaceuticals
Abramson Cancer Center at Penn Medicine
University of Iowa
Memorial Sloan Kettering Cancer Center
UNICANCER
Medical College of Wisconsin
IGM Biosciences, Inc.
TopAlliance Biosciences
EpicentRx, Inc.
Centre Antoine Lacassagne
Grupo Espanol de Investigacion en Sarcomas
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Stanford University
Tracon Pharmaceuticals Inc.
Eastern Cooperative Oncology Group
Grupo Espanol de Investigacion en Sarcomas
Emerald Clinical Inc.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Genentech, Inc.
Celgene
Peking University People's Hospital
Peking University People's Hospital
Washington University School of Medicine
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
N.N. Petrov National Medical Research Center of Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sarcoma Alliance for Research through Collaboration
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Wake Forest University Health Sciences
Peking University People's Hospital
AEterna Zentaris
Assaf-Harofeh Medical Center
Centre Leon Berard
Massachusetts General Hospital
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
University of Miami
Novartis